Vapo Health raises tens of millions of yuan in Series B for nebulisation tech

What's the deal? Vapo HealthDealroom has a profile for this one. Try Dealroom →, a Chinese developer of respiratory healthcare devices, has raised tens of millions of yuan in a Series B round, the company announced in September 2026. The round drew CICC CapitalDealroom has a profile for this one. Try Dealroom →, Kunshan Hi-Tech Group, Shenzhen Capital Group, and Yujian Future.

What's the endgame? The company builds respiratory devices using nano-scale atomising micropore technology, which it says keeps drug and particle dynamics stable during nebulisation treatment. Its lineup includes nebulisers, spacer chambers, temperature-measurement devices, and smart breathing trainers.

Who's behind it? Vapo Health also offers OEM and ODM services, supplying devices for other brands alongside its own products.

The signal: The backing of state-linked investors such as Shenzhen Capital Group and Kunshan Hi-Tech Group points to continued interest in domestic medical-device manufacturing in China.

Image credit: cnordic